COMMUNIQUÉS West-GlobeNewswire

ORION CORPORATION: ACQUISITION OF OWN SHARES 09.05.2019
09/05/2019
Orion Corporation NOTIFICATION 09.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 09.05.2019 Date 09.05.2019 Exchange transaction Buy Share class ORNBV Amount 35,000 Average price/share 29.4723 EUR Highest [...]
The Alliance for Regenerative Medicine Releases Q1 2019 Data Report, Highlighting Sector Trends and Metrics
09/05/2019
WASHINGTON, D.C., May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene [...]
Philips announces collaboration with Medtronic to further advance the image-guided treatment of atrial fibrillation
09/05/2019
May 9, 2019 Philips’ integrated solution will combine the unique KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software, and services to support cryoablation procedures [...]
Abeona Therapeutics annonce la présentation des données concernant EB-101 lors de la Réunion annuelle de la Society for Investigative Dermatology
09/05/2019
NEW YORK et CLEVELAND, 09 mai 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), entreprise de premier plan entièrement intégrée spécialisée dans les thérapies géniques et cellulaires, a annoncé aujourd' [...]
Guardion’s Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Function (CSF) vs AREDS 2
09/05/2019
In a recent study presented at the Association for Research in Vision and Ophthalmology (ARVO) 2019 annual meeting, improvements in visual function (CSF) in the Lumega-Z Group were statistically significant and [...]
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation
09/05/2019
Technology will be utilized in future drug development TALLASSEE, Ala., May 09, 2019 (GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid [...]
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
09/05/2019
Valby, Denmark, 9 May 2019 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. 1. Details of [...]
Podimetrics Raises $13.4 Million to Expand Innovative Solution for Diabetes Complications
09/05/2019
Investment will accelerate the company's business development among VA hospitals and commercial payers SOMERVILLE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Podimetrics , a care management company with the leading [...]
Philips Annual General Meeting of Shareholders re-appoints CEO Frans van Houten and CFO Abhijit Bhattacharya
09/05/2019
May 9, 2018 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today’s Annual General Meeting of Shareholders (AGM) re-appointed Frans van Houten as President/CEO and member of the Board of [...]
Driven Deliveries Inc. Receives New Delivery License, Significantly Expands California Footprint
09/05/2019
Driven Deliveries to serve 92% of California’s cannabis market SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (OTC:DRVD), the first and only cannabis delivery company to be publicly traded on a [...]
Sienna Biopharmaceuticals to Present at BAML Health Care Conference
09/05/2019
WESTLAKE VILLAGE, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna, [...]
Zosano Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
09/05/2019
FREMONT, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has issued and sold an additional 750,000 shares of common [...]
Aptevo Therapeutics Reports First Quarter 2019 Financial Results
09/05/2019
Achieves 73% Increase in First Quarter 2019 Year-Over-Year IXINITY® Net Revenue On Target for Launch of New 3,000 IU IXINITY Assay Mid-2019 Advances Enrollment in APVO436 and APVO210 Phase 1 Clinical Studies; [...]
AXIM® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms
09/05/2019
Leading cannabinoid biotechnology company files U.S. provisional patent application on a chewing gum composition comprising cannabinoids and feverfew extract for the treatment of symptoms that accompany migraines NEW [...]
Predictive Technology Group Finalizes Board Committee Chair Appointments
09/05/2019
SALT LAKE CITY , May 09, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical intervention through [...]
GW Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019
09/05/2019
LONDON, May 09, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and [...]
American Cannabis Company, Inc. Provides Company Update On Overall Progress & Recent Activities
09/05/2019
DENVER, CO, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, wishes to [...]
Harpoon Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
Continued enrollment of Phase 1 trial for HPN424, Harpoon’s lead TriTAC product candidate in development for the treatment of prostate cancer Net proceeds of approximately $71 million from completion of initial public [...]
Bellerophon Provides Business Update and Reports First Quarter 2019 Financial Results
09/05/2019
WARREN, N.J., May 09, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]

Pages